Detailed Mechanism Funding and Narrative

Details for Mechanism ID: 7341
Country/Region: Cambodia
Year: 2008
Main Partner: U.S. Centers for Disease Control and Prevention
Main Partner Program: NA
Organizational Type: Own Agency
Funding Agency: HHS/CDC
Total Funding: $1,006,275

Funding for Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT): $55,500

USG staff members provide direct technical support in this program area to the Ministry of Health and its

National Centers, and to the Provincial Governments of Banteay Meanchey, Battambang, Pailin and Pursat.

CDC collaborates with USAID and its partners to assist in the implementation of activities.

This funding is for the portion of the contract of the HIV Clinical Advisor dedicated to PMTCT. These

activities will include providing supervision to the Program Development Officer with primary responsibility of

introducing HIV screening services at 81 health centers in the provinces cited above, serving as liaison

between USG and the National Center for HIV, AIDS, Dermatology and STDs (NCHADS) and the National

Maternal Child Health Center (NMCHC). The USG HIV clinical advisor will facilitate lessons learned from

the roll out of increasing access to testing for pregnant women, providing consultation to USG implementing

agencies upon request as they plan their support for PMTCT activities, and to continue to serve on the

PMTCT Technical Working Group as it implements recommendations made by the Joint Review of the

PMTCT Program conducted in 9/07 as a collaboration between USG, UNICEF, WHO, the World Bank, the

Royal Government of Cambodia, and local stakeholders.

Funding for Care: TB/HIV (HVTB): $85,615

USG staff members provide direct technical support in this program area to the Ministry of Health and its

National Centers, and to the Provincial Governments of Banteay Meanchey, Battambang, Pailin and Pursat.

The USG and its partners assist in the implementation of activities.

This funding is for the portion of the contracts of the HIV Clinical Advisor and the Microbiologist dedicated to

TB/HIV activities. The activities of the HIV Clinical Advisor that these monies support include participation

in sub-technical working group on TB/HIV at the National TB Program (NTP) and the National Center for

HIV/AIDS, Dermatology, an STDs (NCHADS) to update clinical guidelines on evaluation of HIV positive

patients for TB and the screening of TB patients for HIV, as well as the management of co-infection;

ongoing assistance in implementing Provider Initiated Testing and Counseling; oversight of implementation

of TB screening tools being introduced in Banteay Meanchey; oversight of TB infection control activities

supported by USG, consultation upon request to USG implementing partners to help assure harmonization

of activities within USG, supervision and oversight of a demonstration project in the cited provinces in which

screening for HIV is offered at point of service for TB; and serving as liaison between USG and NTP and

NCHADS as USG hopes that lessons learned from demonstration project can be translated into national

policy.

The activities of the microbiologist that these monies support include technical assistance to the NTP in

implementation of the five year strategic plan for laboratory development that he authored for the NTP in

2006, development of EQA panels for sputum smears and for CD4 testing, training of laboratory staff at the

National TB Program in mycobacterium liquid culture technique, which will facilitate the diagnosis of TB

especially in PLWHAs (who have increased likelihood of sputum smear negative TB), helping NCHADS and

NTP establish guidelines for the rational use of the laboratory in the management of PLWHAs with TB

disease, and serving as liaison between USG and the National Institute of Public Health Laboratory.

Funding for Treatment: Adult Treatment (HTXS): $74,000

USG staff provide direct technical support in this program area to the Ministry of Health and its National

Centers, and to the Provincial Governments of Banteay Meanchey, Battambang, Pailin and Pursat. The

USG and its partners to assist in the implementation of activities.

This funding is for the portion of the contract of the HIV Clinical Advisor dedicated to ART activities. Those

activities include assistance provided to the National Center for HIV, AIDS, Dermatology, and STDs

(NCHADS) in developing a Quality Assurance (QA) Program to be piloted in the above provinces,

assistance to provinces as QA activities are initiated including support to clinical mentors in identifying

quality concerns and interventions to address those concerns, plus evaluation of impact of QA program on

actual quality of care; participation in meetings of regional clinical network and clinical symposia; and

participation in appropriate NCHADS technical working groups.

Funding for Laboratory Infrastructure (HLAB): $167,733

This is an ongoing activity.

The USG will provide direct technical support in this program area to the Ministry of Health and its National

Centers, and to the Governments of Banteay Meanchey, Battambang, and Pursat provinces and Pailin

municipality. The USG and its partners will assist in the implementation of laboratory activities required for

diagnosis of HIV and TB and monitoring of patient care and treatment.

This funding is for the portion of the salary of the Senior Laboratory Scientist (USG direct hire) and the

contract of the Clinical Microbiology Advisor dedicated to laboratory activities.

The Senior Laboratory Scientist provides technical assistance and consultation in support of the USG effort

to develop and strengthen laboratory capacity of the National Institute of Public Health (NIPH). This staff

identifies, evaluates, and provides training in advanced serologic, immunologic, and molecular technology

applicable to the detection and characterization of HIV and associated infectious agents; recognizes and

defines problems in diagnostic testing and evaluates methods for solution, and recommends addition of new

tests to the laboratory services, as needed; and participates in the countrywide effort to establish a quality

assurance system at the provincial and operational district hospital laboratory level.

The Clinical Microbiology Advisor provides expert advice and consultation on all aspects of laboratory

management as it relates to HIV, TB, and other opportunistic infections. Other major activities include

serving as an advisor to NIPH to expand the NIPH Laboratory (NIPHL) as a national reference laboratory

for local and provincial hospitals, determine reference and training needs of provincial and operational

district hospital laboratories, ensure the adequacy of scientific knowledge needed in the performance of

diagnostic tests and research. The Clinical Microbiology Advisor works with the National Laboratory Sub-

Committee, laboratory professionals, epidemiologists, and infectious disease specialists to improve the

capacity of Cambodia's public health and hospital laboratories to diagnose HIV and TB and to clinically

monitor patients on ARV treatment with an emphasis on quality assurance.

Funding for Strategic Information (HVSI): $177,053

USG staff members provide direct technical support in this program area to the Ministry of Health (MOH)

and its National Centers, and to the Governments of Banteay Meanchey, Battambang, and Pursat

provinces and Pailin municipality.

This funding will support salary, benefits, and official travel costs for the epidemiologist dedicated to

strategic information activities. As a member of the PEPFAR SI Team, this staff will provide technical

assistance (TA) to Royal Government of Cambodia Agencies including MOH; the National Center for

HIV/AIDS, Dermatology, and STDs (NCHADS); the National Institute of Public Health (NIPH); and other

USG partners, in particular Family Health International (FHI), in the area of strategic information to

strengthen capacity for collecting, analyzing, interpreting, reporting, and using data for program

implementation, monitoring, evaluation, and planning. Specifically, the USG epidemiologist will work with

NCHADS, NIPH, and FHI to design surveys; develop survey and laboratory protocols, field manuals, and

training workshops for provincial/municipal survey teams; assist with field supervision; provide technical

assistance in the areas of data cleaning, analysis, interpretation, presentation, and reporting; and serve as a

member on various HIV and STI surveillance technical working groups and consensus working groups on

estimation and projections.

Funding for Health Systems Strengthening (OHSS): $161,205

This is an ongoing activity.

In FY 08, USG staff members will continue to provide direct technical support in this program area to the

Ministry of Health and its National Centres, and to the Provincial Governments of Banteay Meanchey,

Battambang, Pailin and Pursat. The USG collaborates with its partners to assist in the implementation of

activities.

This funding is for the portion of the salary of the CDC GAP Director and Associate Director dedicated to

policy development and system strengthening. This includes work with the National Center for HIV/AIDS,

Dermatology and STDs (NCHADS), the National Maternal and Child Health Center (NMCHC), and other

key partners within the Ministry of Health to develop improved policies and operations. This also includes

work with other bilateral donors, multilateral organizations, and NGOs to coordinate activities, particularly as

they relate to the Ministry of Health and the Global Fund grants.

This activity relates to CDC_Post_Base-Other, as well as with other activitiy areas such as PMTCT, TB/HIV,

and Lab within the NCHADS and NIPH cooperative agreements, where considerable effort is underway to

revise policies and procedures related to HIV-screening.

Funding for Management and Operations (HVMS): $285,169

This activity includes $195,169 in costs for portions of the salaries of the CDC GAP Director and Associate

Director associated with management and administration of the program. In addition, this activity includes

the following operations costs:

Headquarters-based travel - $20,000. This would cover two TDYs in excess of 2 weeks for management

and staffing, one for COP preparation for FY09 and one for temporary coverage during home leave of the

associate director.

Shipping - $30,000. This would cover shipping of materials from headquarters to Cambodia. Included in

this are any charges for shipping personal effects for direct hire moves.

Supplies - $20,000. This covers credit-card purchase of supplies, including office, IT and laboratory

supplies.

Equipment - $20,000. This covers credit-card purchase or headquarters-based purchase of equipment,

including laboratory equipment and small office equipment items not available or not reasonably priced in

Cambodia.